| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 7.969 | 21.372 | 31.379 | 39.268 | 49.442 | 16.218 | 17.445 | 23.882 | 11.889 | 0 |
| Total Income - EUR | 7.971 | 21.386 | 31.392 | 39.269 | 49.443 | 16.218 | 17.445 | 25.198 | 12.618 | 3.023 |
| Total Expenses - EUR | 7.615 | 19.612 | 30.310 | 22.249 | 39.158 | 31.434 | 22.388 | 19.974 | 9.558 | 20.777 |
| Gross Profit/Loss - EUR | 356 | 1.774 | 1.083 | 17.020 | 10.285 | -15.215 | -4.943 | 5.224 | 3.059 | -17.754 |
| Net Profit/Loss - EUR | 117 | 1.132 | 141 | 15.949 | 9.054 | -15.700 | -5.466 | 4.522 | 2.585 | -17.827 |
| Employees | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Imunoplant Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 180 | 16.412 | 21.950 | 38.719 | 29.029 | 15.713 | 6.746 | 631 | 0 | 0 |
| Current Assets | 8.604 | 14.022 | 13.756 | 25.867 | 38.079 | 39.185 | 42.824 | 36.326 | 38.479 | 15.598 |
| Inventories | 1.378 | 3.861 | 529 | 803 | 1.042 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 5.641 | 9.990 | 13.404 | 24.019 | 34.545 | 37.987 | 42.319 | 35.775 | 38.302 | 15.539 |
| Cash | 1.584 | 171 | -176 | 1.044 | 2.492 | 1.198 | 505 | 552 | 177 | 59 |
| Shareholders Funds | 6.935 | 7.996 | 8.002 | 23.804 | 32.398 | 16.100 | 10.277 | 14.830 | 17.406 | -518 |
| Social Capital | 67 | 67 | 66 | 64 | 63 | 79 | 77 | 77 | 77 | 76 |
| Debts | 9.428 | 22.438 | 27.705 | 40.781 | 35.150 | 39.229 | 39.714 | 22.127 | 21.483 | 16.116 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "1729 - 1729" | |||||||||
| CAEN Financial Year |
8710
|
|||||||||
Comments - Imunoplant Srl